<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04540068</url>
  </required_header>
  <id_info>
    <org_study_id>POTEISS</org_study_id>
    <nct_id>NCT04540068</nct_id>
  </id_info>
  <brief_title>Prediction of TEI Success in Sciatica</brief_title>
  <acronym>POTEISS</acronym>
  <official_title>Prediction Of Transforaminal Epidural Injection Success in Sciatica</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EJAVerheijen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Spaarne Gasthuis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Leiden University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: Treatment with transforaminal epidural injections is part of usual care in&#xD;
      patients suffering from sciatica. However, not all patients experience a satisfactory result&#xD;
      from this treatment and it is unclear what percentage of patients responds well and if any&#xD;
      clinical or radiological factors exist that predict a positive response.&#xD;
&#xD;
      Objectives:&#xD;
&#xD;
      Primary: to determine the average leg pain score two weeks after treatment with TEI in&#xD;
      patients with sciatica due to LDH and due to spinal stenosis.&#xD;
&#xD;
      Secondary: to determine the average score for leg pain, back pain, functionality, anxiety and&#xD;
      depression, pain coping, patient satisfaction and overall health status postprocedural and at&#xD;
      2 weeks and 6 weeks after TEI, and to explore radiological and clinical factors that predict&#xD;
      TEI success.&#xD;
&#xD;
      Study design: Prospective cohort study&#xD;
&#xD;
      Study population: Patients that are scheduled for TEI as part of usual care suffering from a&#xD;
      first episode of sciatica&#xD;
&#xD;
      Main study parameters/endpoints: The mean leg pain score at 2 weeks after treatment with TEI.&#xD;
      Leg pain, back pain, functionality, patient satisfaction, anxiety and depression, pain coping&#xD;
      and quality of life post-procedural and at 2 and 6 weeks follow-up.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2020</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Numerical Rating Scale Leg Pain</measure>
    <time_frame>2 weeks</time_frame>
    <description>The NRS score for leg pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numerical Rating Scale Leg Pain</measure>
    <time_frame>30 minutes after treatment</time_frame>
    <description>The NRS score for leg pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numerical Rating Scale Leg Pain</measure>
    <time_frame>6 weeks</time_frame>
    <description>The NRS score for leg pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numerical Rating Scale Back Pain</measure>
    <time_frame>30 minutes after treatment</time_frame>
    <description>The NRS score for back pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numerical Rating Scale Back Pain</measure>
    <time_frame>2 weeks</time_frame>
    <description>The NRS score for back pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numerical Rating Scale Back Pain</measure>
    <time_frame>6 weeks</time_frame>
    <description>The NRS score for back pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>2 weeks</time_frame>
    <description>The ODI score for functionality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>6 weeks</time_frame>
    <description>The ODI score for functionality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Perceived Effect</measure>
    <time_frame>2 weeks</time_frame>
    <description>The degree of patient satisfaction from experienced recovery on a Likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Perceived Effect</measure>
    <time_frame>6 weeks</time_frame>
    <description>The degree of patient satisfaction from experienced recovery on a Likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale</measure>
    <time_frame>2 weeks</time_frame>
    <description>The HADS score for assessment of anxiety and depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale</measure>
    <time_frame>6 weeks</time_frame>
    <description>The HADS score for assessment of anxiety and depression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Coping Inventory</measure>
    <time_frame>2 weeks</time_frame>
    <description>Assessment of the pain coping mechanisms of the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Coping Inventory</measure>
    <time_frame>6 weeks</time_frame>
    <description>Assessment of the pain coping mechanisms of the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale Quality of Life</measure>
    <time_frame>2 weeks</time_frame>
    <description>The VAS for assessment of Quality of Life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale Quality of Life</measure>
    <time_frame>6 weeks</time_frame>
    <description>The VAS for assessment of Quality of Life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of pain medication and physical therapy</measure>
    <time_frame>2 weeks</time_frame>
    <description>Use of pain medication and physical therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of pain medication and physical therapy</measure>
    <time_frame>6 weeks</time_frame>
    <description>Use of pain medication and physical therapy</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">538</enrollment>
  <condition>Sciatica</condition>
  <condition>Lumbar Disc Herniation</condition>
  <condition>Lumbar Spinal Stenosis</condition>
  <condition>Lumbar Radiculopathy</condition>
  <arm_group>
    <arm_group_label>Patients with Lumbar Disc Herniation</arm_group_label>
    <description>Patients with a lumbar disc herniation on MRI and consistent with clinical findings are screened if they have an appointment at the pain clinic for treatment with a transforaminal epidural injection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with Lumbar Spinal Stenosis</arm_group_label>
    <description>Patients with a lumbar spinal stenosis on MRI and consistent with clinical findings are screened if they have an appointment at the pain clinic for treatment with a transforaminal epidural injection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Transforaminal Epidural Injection</intervention_name>
    <description>Injections above L3 will contain 1,5 ml lidocaine 1% and 10 mg dexamethasone and injections at L3 or below will contain 1,5 ml lidocaine 2% and 40mg methylprednisolone acetate in accordance with current Dutch anesthesiologic guidelines for usual care.</description>
    <arm_group_label>Patients with Lumbar Disc Herniation</arm_group_label>
    <arm_group_label>Patients with Lumbar Spinal Stenosis</arm_group_label>
    <other_name>Transforaminal Epidural Steroid Injection</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients suffering from sciatica due to lumbar disc herniation or spinal stenosis that have&#xD;
        a scheduled appointment for treatment with TEI are screened to be candidates for this&#xD;
        study. If the patient fulfills the inclusion and exclusion criteria the patient can&#xD;
        participate in this study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of first episode of sciatica secondary to lumbar disc herniation or spinal&#xD;
             stenosis&#xD;
&#xD;
          -  Diagnosis confirmed by Magnetic Resonance Imaging&#xD;
&#xD;
          -  Access to e-mail&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age under 18 years&#xD;
&#xD;
          -  Severe scoliosis&#xD;
&#xD;
          -  History of back surgery&#xD;
&#xD;
          -  Epidural injection received in 12 months before date of participation&#xD;
&#xD;
          -  Circumstances that prevent treatment with Transforaminal Epidural Injection (e.g. use&#xD;
             of anticoagulants that cannot be temporarily discontinued)&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carmen LA Vleggeert-Lankamp, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Leiden University Medical Centre / Spaarne Gasthuis</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eduard JA Verheijen, Bsc.</last_name>
    <phone>+3171526746</phone>
    <email>e.j.a.verheijen@lumc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carmen LA Vleggeert-Lankamp, MD, PhD</last_name>
    <phone>+31715262093</phone>
    <email>c.l.a.vleggeert-lankamp@lumc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Spaarne Gasthuis</name>
      <address>
        <city>Haarlem</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Vroomen PC, de Krom MC, Knottnerus JA. Predicting the outcome of sciatica at short-term follow-up. Br J Gen Pract. 2002 Feb;52(475):119-23.</citation>
    <PMID>11887877</PMID>
  </reference>
  <reference>
    <citation>Şencan S, Çelenlioğlu AE, Asadov R, Gündüz OH. Predictive factors for treatment success of transforaminal epidural steroid injection in lumbar disc herniation-induced sciatica. Turk J Med Sci. 2020 Feb 13;50(1):126-131. doi: 10.3906/sag-1908-167.</citation>
    <PMID>31742372</PMID>
  </reference>
  <reference>
    <citation>Billy GG, Lin J, Gao M, Chow MX. Predictive Factors of the Effectiveness of Caudal Epidural Steroid Injections in Managing Patients With Chronic Low Back Pain and Radiculopathy. Clin Spine Surg. 2017 Jul;30(6):E833-E838. doi: 10.1097/BSD.0000000000000454.</citation>
    <PMID>27764056</PMID>
  </reference>
  <reference>
    <citation>Lee JW, Kim SH, Lee IS, Choi JA, Choi JY, Hong SH, Kang HS. Therapeutic effect and outcome predictors of sciatica treated using transforaminal epidural steroid injection. AJR Am J Roentgenol. 2006 Dec;187(6):1427-31.</citation>
    <PMID>17114531</PMID>
  </reference>
  <reference>
    <citation>McCormick Z, Cushman D, Casey E, Garvan C, Kennedy DJ, Plastaras C. Factors associated with pain reduction after transforaminal epidural steroid injection for lumbosacral radicular pain. Arch Phys Med Rehabil. 2014 Dec;95(12):2350-6. doi: 10.1016/j.apmr.2014.07.404. Epub 2014 Aug 7.</citation>
    <PMID>25108099</PMID>
  </reference>
  <reference>
    <citation>Cyteval C, Fescquet N, Thomas E, Decoux E, Blotman F, Taourel P. Predictive factors of efficacy of periradicular corticosteroid injections for lumbar radiculopathy. AJNR Am J Neuroradiol. 2006 May;27(5):978-82.</citation>
    <PMID>16687527</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 1, 2020</study_first_submitted>
  <study_first_submitted_qc>September 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 7, 2020</study_first_posted>
  <last_update_submitted>September 5, 2020</last_update_submitted>
  <last_update_submitted_qc>September 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Leiden University Medical Center</investigator_affiliation>
    <investigator_full_name>EJAVerheijen</investigator_full_name>
    <investigator_title>Bsc.</investigator_title>
  </responsible_party>
  <keyword>Transforaminal Epidural Injection</keyword>
  <keyword>Lumbar spine</keyword>
  <keyword>Prospective cohort study</keyword>
  <keyword>Prediction of success</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Stenosis</mesh_term>
    <mesh_term>Radiculopathy</mesh_term>
    <mesh_term>Sciatica</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

